Scoliosis Market Report 2026

The scoliosis market size has grown steadily in recent years. It will grow from $1.26 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 2.4%. The growth in the historic period can be attributed to limited screening programs, traditional surgical approaches, delayed diagnosis, lack of awareness, inadequate rehabilitation protocols.

The scoliosis market size is expected to see steady growth in the next few years. It will grow to $1.4 billion in 2030 at a compound annual growth rate (CAGR) of 2.2%. The growth in the forecast period can be attributed to robotic-assisted surgeries, early detection technologies, wearable monitoring devices, personalized bracing solutions, telehealth rehabilitation. Major trends in the forecast period include early screening programs, non-surgical bracing adoption, minimally invasive spinal surgeries, robotic-assisted correction, tele-rehabilitation solutions.

The rising incidence of bone mineral deficiencies is expected to drive the growth of the scoliosis market in the coming years. Bone mineral deficiencies refer to a lack of essential minerals in the bones, leading to weakened bone structure and an increased risk of fractures. Factors such as aging, poor nutrition, vitamin D deficiency, sedentary lifestyles, and certain medical conditions are contributing to the growing prevalence of these deficiencies. Scoliosis can exacerbate bone mineral deficiencies by impacting bone density and structural integrity, thereby increasing the risk of osteoporosis and fractures. For example, in March 2024, the National Institutes of Health (NIH), a US-based agency, reported that among 5,380 Romanian adults aged 25-64 years, 24.8% had vitamin D deficiency. Additionally, the UK Department of Health and Social Care indicated that approximately one in six adults in the UK has low vitamin D levels. Consequently, the increasing incidence of bone mineral deficiencies is fueling the growth of the scoliosis market.

Key companies in the scoliosis market are focusing on innovative products, such as the growing rod system, to improve treatment outcomes, correct spinal deformities, and reduce the need for multiple surgeries in pediatric scoliosis patients. The growing rod system is an adjustable spinal implant used to treat early-onset scoliosis, allowing controlled spinal growth while minimizing repeated surgical interventions. For instance, in July 2023, Globus Medical, a US-based medical device company, launched the MARVEL growing rod system. This device is designed to manage early-onset scoliosis by enabling controlled spinal growth and features a non-invasive adjustment mechanism that reduces the need for repeated surgeries. The system aims to enhance patient outcomes by providing a customizable and less intrusive treatment option.

In September 2023, Globus Medical, a US-based medical device company, merged with NuVasive Inc. to create a leading musculoskeletal technology firm. This merger combines their expertise in spinal surgery to drive innovation, improve operational efficiency, and enhance patient outcomes. NuVasive Inc., also US-based, specializes in innovative minimally invasive solutions for spinal disorders, including scoliosis treatment.

Major companies operating in the scoliosis market are Medtronic plc, Zimmer Biomet Holdings Inc., Stryker Corporation, Ottobock SE & Co. KGaA, Enovis Corporation, Globus Medical Inc., Össur Corporate, Alphatec Spine Inc., Trulife Group, OrthoPediatrics Corp., Aspen Medical Products LLC, Bauerfeind AG, Boston Orthotics & Prosthetics, Spinal Technology Inc., Horton's Orthotics & Prosthetics, Chaneco Limited, Optec USA Inc., LA Brace Center, Beacon Prosthetics and Orthotics Inc., Spinologics Inc., UNYQ Inc.

North America was the largest region in the scoliosis market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the scoliosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the scoliosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have created cost and supply challenges for the scoliosis market by increasing prices for imported spinal implants, braces, rods, screws, and rehabilitation equipment that are essential for both surgical and non-surgical treatment. Hospitals and clinics in Asia-Pacific and Latin America, which rely heavily on imported orthopedic devices, have been most affected, leading to delayed procedures and higher out-of-pocket expenses for patients. These cost pressures have also affected manufacturers of advanced bracing systems and growth modulation devices that depend on global component sourcing. However, the tariffs are encouraging local manufacturing and regional sourcing of orthopedic products, which is gradually improving supply chain resilience and promoting long-term competitiveness in the scoliosis market.

The scoliosis market research report is one of a series of new reports that provides scoliosis market statistics, including scoliosis industry global market size, regional shares, competitors with a scoliosis market share, detailed scoliosis market segments, market trends and opportunities, and any further data you may need to thrive in the scoliosis industry. This scoliosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Scoliosis is a medical condition marked by an abnormal lateral curvature of the spine. It can occur in both children and adults and may range in severity, sometimes necessitating treatments such as bracing or surgery. The condition may be idiopathic (of unknown cause), congenital (present at birth), or neuromuscular (linked to disorders such as cerebral palsy or muscular dystrophy).

The primary product types for scoliosis include bracing, physiotherapy, surgical devices, and other related products. Scoliosis bracing is a non-surgical intervention that employs custom-fitted external braces to halt the progression of spinal curvature in children and adolescents. This treatment is mainly used across different age groups, including children, teenagers, and adults, with end-users comprising hospitals, clinics, home care settings, and other relevant facilities.

The scoliosis market consists of revenues earned by entities by providing services such as screening and diagnosis, non-surgical treatment, surgical treatment, rehabilitation, and pain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The scoliosis market also includes sales of diagnostic devices and treatment solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.